Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma

被引:72
|
作者
Landwehr, Laura-Sophie [1 ]
Altieri, Barbara [1 ]
Schreiner, Jochen [1 ]
Sbiera, Iuliu [1 ]
Weigand, Isabel [1 ]
Kroiss, Matthias [1 ,2 ]
Fassnacht, Martin [1 ,2 ,3 ]
Sbiera, Silviu [1 ,2 ]
机构
[1] Univ Hosp Wurzburg, Dept Internal Med 1, Div Endocrinol & Diabet, Wurzburg, Germany
[2] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Clin Chem & Lab Med, Wurzburg, Germany
关键词
immunity; immunotherapy; lymphocytes; tumor-infiltrating; t-lymphocytes; tumor microenvironment; REGULATORY T-CELLS; EUROPEAN-SOCIETY; PHASE-II; CANCER; COLLABORATION; PEMBROLIZUMAB; MANAGEMENT; NIVOLUMAB; SURVIVAL; EFFICACY;
D O I
10.1136/jitc-2019-000469
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Tumor-related glucocorticoid excess is present in similar to 60% of patients and associated with particularly poor prognosis. Results of first clinical trials using immune checkpoint inhibitors were heterogeneous. Here we characterize tumor-infiltrating T lymphocytes (TILs) in ACC in association with glucocorticoids as potential explanation for resistance to immunotherapy. Methods We performed immunofluorescence analysis to visualize tumor-infiltrating T cells (CD3(+)), T helper cells (CD3(+)CD4(+)), cytotoxic T cells (CD3(+)CD8(+)) and regulatory T cells (Tregs; CD3(+)CD4(+)FoxP3(+)) in 146 ACC tissue specimens (107 primary tumors, 16 local recurrences, 23 metastases). Quantitative data of immune cell infiltration were correlated with clinical data (including glucocorticoid excess). Results 86.3% of ACC specimens showed tumor infiltrating T cells (7.7 cells/high power field (HPF)), including T helper (74.0%, 6.7 cells/HPF), cytotoxic T cells (84.3%, 5.7 cells/HPF) and Tregs (49.3%, 0.8 cells/HPF). The number of TILs was associated with better overall survival (HR for death: 0.47, 95% CI 0.25 to 0.87), which was true for CD4(+)- and CD8(+) subpopulations as well. In localized, non-metastatic ACC, the favorable impact of TILs on overall and recurrence-free survival was manifested even independently of ENSAT (European Network for the Study of Adrenal Tumors) stage, resection status and Ki67 index. T helper cells were negatively correlated with glucocorticoid excess (Phi=-0.290, p=0.009). Patients with glucocorticoid excess and low TILs had a particularly poor overall survival (27 vs. 121 months in patients with TILs without glucocorticoid excess). Conclusion Glucocorticoid excess is associated with T cell depletion and unfavorable prognosis. To reactivate the immune system in ACC by checkpoint inhibitors, an inhibition of adrenal steroidogenesis might be pivotal and should be tested in prospective studies.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Tumor-Infiltrating Lymphocytes in Melanoma
    Sylvia Lee
    Kim Margolin
    Current Oncology Reports, 2012, 14 : 468 - 474
  • [32] A New Model to Improve the Prediction of Prognosis of Endometrial Carcinoma by Combining Traditional Classification With the Presence of Tumor-infiltrating Lymphocytes
    Miyamoto, Morikazu
    Hada, Taira
    Ishibashi, Hiroki
    Iwahashi, Hideki
    Kakimoto, Soichiro
    Suzuki, Rie
    Sakamoto, Takahiro
    Matsuura, Hiroko
    Tsuda, Hitoshi
    Takano, Masashi
    ANTICANCER RESEARCH, 2021, 41 (02) : 1047 - 1053
  • [33] Relationships between tumor CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinoma
    Shigematsu, Yasuyuki
    Kanda, Hiroaki
    Takahashi, Yu
    Takeuchi, Kengo
    Inamura, Kentaro
    VIRCHOWS ARCHIV, 2024,
  • [34] Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies
    Castaneda, Carlos A.
    Castillo, Miluska
    Aliaga, Karina
    Bernabe, Luis A.
    Casavilca, Sandro
    Sanchez, Joselyn
    Torres-Cabala, Carlos A.
    Gomez, Henry L.
    Mas, Luis
    Dunstan, Jorge
    Cotrina, Jose M.
    Abugattas, Julio
    Chavez, Ivan
    Ruiz, Eloy
    Montenegro, Paola
    Rojas, Victor
    Orrego, Enrique
    Galvez-Nino, Marco
    Felix, Brayam
    Landa-Baella, Maria P.
    Vidaurre, Tatiana
    Villa, Maria R.
    Zevallos, Rocio
    Taxa, Luis
    Guerra, Henry
    BIOMARKERS IN MEDICINE, 2019, 13 (17) : 1481 - 1491
  • [35] Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes
    Iams, Wade T.
    Shiuan, Eileen
    Meador, Catherine B.
    Roth, Marc
    Bordeaux, Jennifer
    Vaupel, Christine
    Boyd, Kelli L.
    Summitt, IlaSri B.
    Wang, Lucy L.
    Schneider, Joseph T.
    Warner, Jeremy L.
    Zhao, Zhiguo
    Lovly, Christine M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : 1970 - 1981
  • [36] Impact of Tumor-Infiltrating Lymphocytes on Disease Progression in Human Papillomavirus-Related Oropharyngeal Carcinoma
    Yin, Linda X.
    Rivera, Michael
    Garcia, Joaquin J.
    Bartemes, Kathleen R.
    Lewis, Derrick B.
    Lohse, Christine M.
    Routman, David M.
    Ma, Daniel J.
    Moore, Eric J.
    Van Abel, Kathryn M.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2023, 169 (03) : 539 - 547
  • [37] Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor Era
    Linette, Gerald P.
    Carreno, Beatriz M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (04) : 286 - 291
  • [38] Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management
    Ken Shirabe
    Takashi Motomura
    Jun Muto
    Takeo Toshima
    Rumi Matono
    Yohei Mano
    Kazuki Takeishi
    Hideki Ijichi
    Noboru Harada
    Hideaki Uchiyama
    Tomoharu Yoshizumi
    Akinobu Taketomi
    Yoshihiko Maehara
    International Journal of Clinical Oncology, 2010, 15 : 552 - 558
  • [39] Prognostic Value of Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma
    Spector, Matthew E.
    Bellile, Emily
    Amlani, Lahin
    Zarins, Katie
    Smith, Joshua
    Brenner, J. Chad
    Rozek, Laura
    Nguyen, Ariane
    Thomas, Daffyd
    McHugh, Jonathan B.
    Taylor, Jeremy M. G.
    Wolf, Gregory T.
    Bradford, Carol R.
    Carey, Thomas E.
    Chepeha, Douglas B.
    Duffy, Sonia
    Eisbruch, Avraham
    Helman, Joseph
    Malloy, Kelly M.
    McHugh, Jonathan
    McLean, Scott A.
    Miller, Tamara H.
    Moyer, Jeff
    Prince, Mark E.
    Rogers, Nancy
    Spector, Matthew E.
    Wallace, Nancy E.
    Walline, Heather
    Ward, Brent
    Worden, Francis
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2019, 145 (11) : 1012 - 1019
  • [40] Prognostic Utility of Tumor-Infiltrating Lymphocytes in Noncolorectal Gastrointestinal Malignancies
    Hamza, Ameer
    Khan, Uqba
    Khurram, Muhammad Siddique
    Abraham, Renny
    Mazzara, Paul
    Hadid, Tarik
    Kafri, Zyad
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2019, 27 (03) : 263 - 267